The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways.
 
Emma Pailler
No Relationships to Disclose
 
Laura Mezquita
No Relationships to Disclose
 
Vincent Faugeroux
No Relationships to Disclose
 
Marianne Oulhen
No Relationships to Disclose
 
Pauline Queffelec
No Relationships to Disclose
 
Jordi Remon
Travel, Accommodations, Expenses - Inivata
 
Aurelie Honore
No Relationships to Disclose
 
Mélanie Laporte
No Relationships to Disclose
 
Claudio Forcato
Employment - Menarini Silicon Biosystems
Patents, Royalties, Other Intellectual Property - Zach (I)
 
Yann Lecluse
No Relationships to Disclose
 
Ludovic Lacroix
No Relationships to Disclose
 
Virginie Marty
No Relationships to Disclose
 
Maud Ngocamus
No Relationships to Disclose
 
Claudio Nicotra
No Relationships to Disclose
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MSD Oncology; Novartis; Pfizer; Roche
 
Jean-Charles Soria
Employment - MedImmune
Honoraria - AstraZeneca; Roche; Sanofi; SERVIER
 
Nicolò Manaresi
Employment - Menarini Silicon Biosystems
Leadership - Menarini Silicon Biosystems
Patents, Royalties, Other Intellectual Property - Menarini Silicon Biosystems
 
Francoise Farace
No Relationships to Disclose
 
Benjamin Besse
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Inivata (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); OncoMed (Inst); Onxeo (Inst); ose pharma (Inst); ose pharma (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Novartis; Pfizer; Pierre Fabre; Roche